Analysts Expect Healthpeak Properties (NASDAQ:PEAK) Will Post Quarterly Sales of $685.36 Million

Wall Street brokerages expect Healthpeak Properties (NASDAQ:PEAK) to post sales of $685.36 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Healthpeak Properties’ earnings. The lowest sales estimate is $655.70 million and the highest is $715.01 million. Healthpeak Properties posted sales of $491.57 million in the same quarter last year, which would indicate a positive year over year growth rate of 39.4%. The firm is expected to announce its next quarterly earnings results on Wednesday, July 29th.

On average, analysts expect that Healthpeak Properties will report full-year sales of $2.47 billion for the current year, with estimates ranging from $2.15 billion to $2.72 billion. For the next fiscal year, analysts forecast that the firm will report sales of $2.62 billion, with estimates ranging from $2.21 billion to $2.91 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for Healthpeak Properties.

Healthpeak Properties (NASDAQ:PEAK) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.10. The business had revenue of $585.20 million for the quarter, compared to analysts’ expectations of $531.36 million. The firm’s quarterly revenue was up 34.2% on a year-over-year basis.

Several research analysts have weighed in on the company. Citigroup dropped their price target on Healthpeak Properties from $38.00 to $24.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Raymond James downgraded Healthpeak Properties from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 29th. KeyCorp lowered their price target on Healthpeak Properties from $37.00 to $30.00 and set an “overweight” rating for the company in a research report on Tuesday, April 21st. Barclays restated a “buy” rating and issued a $28.00 price target on shares of Healthpeak Properties in a research report on Wednesday, April 8th. Finally, BMO Capital Markets reiterated a “buy” rating and issued a $30.00 target price on shares of Healthpeak Properties in a research note on Friday, May 22nd. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $28.00.

Healthpeak Properties stock traded up $0.69 during midday trading on Monday, hitting $27.18. The stock had a trading volume of 4,414,345 shares, compared to its average volume of 4,714,025. The stock has a fifty day moving average of $25.67. Healthpeak Properties has a 52-week low of $18.63 and a 52-week high of $37.93.

A number of hedge funds have recently modified their holdings of the stock. Harvest Fund Management Co. Ltd boosted its position in Healthpeak Properties by 10.2% during the first quarter. Harvest Fund Management Co. Ltd now owns 6,329 shares of the company’s stock valued at $150,000 after purchasing an additional 586 shares in the last quarter. Skandinaviska Enskilda Banken AB publ boosted its holdings in Healthpeak Properties by 0.9% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 71,177 shares of the company’s stock worth $1,698,000 after acquiring an additional 600 shares in the last quarter. Reilly Financial Advisors LLC boosted its holdings in Healthpeak Properties by 1.9% in the first quarter. Reilly Financial Advisors LLC now owns 35,010 shares of the company’s stock worth $835,000 after acquiring an additional 650 shares in the last quarter. 6 Meridian boosted its holdings in Healthpeak Properties by 4.0% in the first quarter. 6 Meridian now owns 17,314 shares of the company’s stock worth $413,000 after acquiring an additional 666 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Healthpeak Properties by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 273,173 shares of the company’s stock worth $6,515,000 after acquiring an additional 738 shares in the last quarter.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles.

Recommended Story: How to calculate the intrinsic value of a stock

Get a free copy of the Zacks research report on Healthpeak Properties (PEAK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthpeak Properties (NASDAQ:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.